Argent Trust Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.92M | Buy |
246,598
+8,178
| +3% | +$218K | 0.24% | 104 |
|
|
2025
Q4 | $5.94M | Sell |
238,420
-9,309
| -4% | -$235K | 0.2% | 112 |
|
|
2025
Q3 | $6.31M | Buy |
247,729
+1,456
| +0.6% | +$35.9K | 0.22% | 96 |
|
|
2025
Q2 | $5.97M | Buy |
246,273
+6,914
| +3% | +$161K | 0.23% | 94 |
|
|
2025
Q1 | $6.07M | Buy |
239,359
+7,235
| +3% | +$189K | 0.25% | 89 |
|
|
2024
Q4 | $6.16M | Buy |
232,124
+11,149
| +5% | +$302K | 0.25% | 88 |
|
|
2024
Q3 | $6.4M | Sell |
220,975
-6,492
| -3% | -$189K | 0.26% | 78 |
|
|
2024
Q2 | $6.36M | Sell |
227,467
-1,346
| -0.6% | -$37.1K | 0.28% | 76 |
|
|
2024
Q1 | $6.35M | Sell |
228,813
-7,153
| -3% | -$198K | 0.29% | 79 |
|
|
2023
Q4 | $6.79M | Sell |
235,966
-56,802
| -19% | -$1.72M | 0.34% | 68 |
|
|
2023
Q3 | $9.71M | Sell |
292,768
-2,267
| -0.8% | -$80.2K | 0.53% | 44 |
|
|
2023
Q2 | $10.8M | Buy |
295,035
+36,737
| +14% | +$1.43M | 0.59% | 39 |
|
|
2023
Q1 | $10.5M | Buy |
258,298
+5,718
| +2% | +$247K | 0.67% | 34 |
|
|
2022
Q4 | $12.9M | Buy |
252,580
+8,318
| +3% | +$399K | 0.86% | 25 |
|
|
2022
Q3 | $10.7M | Buy |
244,262
+5,560
| +2% | +$270K | 0.77% | 27 |
|
|
2022
Q2 | $12.5M | Buy |
238,702
+11,383
| +5% | +$580K | 0.86% | 26 |
|
|
2022
Q1 | $11.8M | Buy |
227,319
+13,219
| +6% | +$686K | 0.72% | 31 |
|
|
2021
Q4 | $12.6M | Sell |
214,100
-3,630
| -2% | -$180K | 0.74% | 31 |
|
|
2021
Q3 | $9.36M | Sell |
217,730
-8,988
| -4% | -$398K | 0.6% | 45 |
|
|
2021
Q2 | $8.88M | Sell |
226,718
-559
| -0.2% | -$21.7K | 0.58% | 47 |
|
|
2021
Q1 | $8.23M | Sell |
227,277
-29,994
| -12% | -$1.06M | 0.58% | 48 |
|
|
2020
Q4 | $9.47M | Sell |
257,271
-19,720
| -7% | -$723K | 0.73% | 37 |
|
|
2020
Q3 | $9.64M | Sell |
276,991
-4,674
| -2% | -$164K | 0.85% | 33 |
|
|
2020
Q2 | $8.74M | Sell |
281,665
-30,964
| -10% | -$1.05M | 0.82% | 34 |
|
|
2020
Q1 | $9.68M | Sell |
312,629
-6,832
| -2% | -$233K | 1.09% | 24 |
|
|
2019
Q4 | $11.9M | Buy |
319,461
+20,140
| +7% | +$717K | 1.06% | 24 |
|
|
2019
Q3 | $10.2M | Sell |
299,321
-12,246
| -4% | -$445K | 0.98% | 26 |
|
|
2019
Q2 | $12.8M | Buy |
311,567
+1,572
| +0.5% | +$62.4K | 1.3% | 15 |
|
|
2019
Q1 | $12.5M | Sell |
309,995
-6,415
| -2% | -$257K | 1.31% | 14 |
|
|
2018
Q4 | $13.1M | Buy |
316,410
+61,514
| +24% | +$2.55M | 1.54% | 8 |
|
|
2018
Q3 | $10.5M | Sell |
254,896
-996
| -0.4% | -$38.3K | 1.22% | 14 |
|
|
2018
Q2 | $8.81M | Buy |
255,892
+213,701
| +507% | +$7.3M | 1.07% | 20 |
|
|
2018
Q1 | $1.42M | Buy |
42,191
+6,993
| +20% | +$240K | 0.41% | 63 |
|
|
2017
Q4 | $1.21M | Sell |
35,198
-12,247
| -26% | -$418K | 0.47% | 60 |
|
|
2017
Q3 | $1.61M | Buy |
47,445
+5,519
| +13% | +$177K | 0.63% | 44 |
|
|
2017
Q2 | $1.34M | Sell |
41,926
-2,229
| -5% | -$70.3K | 0.55% | 54 |
|
|
2017
Q1 | $1.43M | Buy |
44,155
+7,343
| +20% | +$232K | 0.59% | 50 |
|
|
2016
Q4 | $1.13M | Buy |
36,812
+64
| +0.2% | +$1.95K | 0.5% | 54 |
|
|
2016
Q3 | $1.18M | Sell |
36,748
-28
| -0.1% | -$936 | 0.5% | 53 |
|
|
2016
Q2 | $1.23M | Buy |
36,776
+199
| +0.5% | +$6.35K | 0.54% | 53 |
|
|
2016
Q1 | $1.03M | Sell |
36,577
-1,365
| -4% | -$39K | 0.5% | 59 |
|
|
2015
Q4 | $1.16M | Buy |
37,942
+8,354
| +28% | +$263K | 0.58% | 54 |
|
|
2015
Q3 | $882K | Sell |
29,588
-5,661
| -16% | -$182K | 0.5% | 63 |
|
|
2015
Q2 | $1.12M | Sell |
35,249
-516
| -1% | -$16.8K | 0.56% | 53 |
|
|
2015
Q1 | $1.18M | Buy |
35,765
+1,628
| +5% | +$51.8K | 0.6% | 50 |
|
|
2014
Q4 | $1.01M | Buy |
+34,137
| New | +$979K | 0.61% | 51 |
|
Other funds holding PFE
VCM
VPM
Argent Trust Co's PFE Position: Q1 2026 in Review
Argent Trust Co increased its Pfizer (PFE) stake by 3.4% in Q1 2026, buying an estimated $218K and bringing the position to 246,598 shares worth $6.92M. The position accounts for 0.24% of the portfolio, ranked #104.
Argent Trust Co first reported a position in PFE in Q4 2014 and has held it in 46 quarters since. The position peaked at $13.1M in Q4 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Argent Trust Co held 246,598 shares of Pfizer worth $6.92M as of Q1 2026.
- Argent Trust Co bought 8,178 Pfizer shares in Q1 2026, an estimated $218K.
- Pfizer made up 0.24% of Argent Trust Co's portfolio in Q1 2026, its #104 holding.
- Argent Trust Co first reported a position in Pfizer in Q4 2014 and has held it in 46 quarters since.
- Argent Trust Co's Pfizer position peaked at $13.1M in Q4 2018.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.